Congenital dyserythropoietic anemia

Crookston JH, Godwin TF, Wjk R, et al. Congenital dyserythropoietic anemia (abstract). XIth congress of the international society of haematology, Sydney: vol. 18; 1966. Heimpel H, Wendt F, Klemm D, et al. Congenital dyserythropoietic anemia. Arch Klin Med. 1968;215:174–94. Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol. 2005;131:431–46. Bessler M, Mason PJ, Link DC. Inherited bone marrow failure syndrome. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE, et al., editors. Hematology of infancy and childhood. 7th ed. Philadelphia: Saunders; 2009. p. 307–95. Dgany O, Avidan N, Delaunay J, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet. 2002;71:1467–74. Greiner TC, Burns CP, Dick FR, et al. Congenital dyserythropoietic anemia type II diagnosed in a 69-year-old patient with iron overload. Am J Clin Pathol. 1992;98:522–5. Iolascon A, Delaunay J, Wickramasinghe SN, et al. Natural history of congenital dyserythropoietic anemia type II. Blood. 2001;98(4):1258–60. Heimpel H. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis. Ann Hematol. 2004;83:613–21. Renella R, Wood WG. The congenital dyserythropoietic anemias. Hematol Oncol Clin N Am. 2009;23:283–306. Heimpel H, Anselstetter V, Chrobak L, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576–5581. Lavabre-Bertrand T, Blanc P, Navarro R, et al. Alpha-interferon therapy for congenital dyserythropoietic anemia type I. Br J Haematol. 1995;89(4):929–32. Shamseddine A, Taher A, Jaafar H, et al. Interferon alpha is an effective therapy for congenital dyserythropoietic anemia type I. Eur J Haematol. 2000;65:207–9. Lavabre-Bertrand T, Ramos J, Delfour C, et al. Long-term alpha interferon treatment is effective ON anemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol. 2004;73:380–3. Marwaha RK, Bansal D, Trehan A, et al. Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol. 2005;22:133–8. Goede JS, Benz R, Fehr J, et al. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy. Ann Hematol. 2006;85:591–5. Ayas M, al-Jefri A, Baothman A, et al. Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogenic stem cell transplantation. Bone Marrow Transplant. 2002;29:681–2. Iolascon A, Sabato V, de Mattia D, et al. Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant. 2001;27:213–5. Remacha AF, Badell I, Pujoi-Moix N, et al. Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood. 2002;100:356–8. Heimpel H, Schwarz K, Ebnother M, et al. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood. 2006;107:334–40. Shalev H, Kapelushnik J, Moser A, et al. A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol. 2004;26:746–8. Parez N, Dommergues M, Zupan V, et al. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy. Br J Haematol. 2000;110:420–3. Shalev H, Kapleushnik Y, Haeskelzon L, et al. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults. Eur J Haematol. 2002;68:170–4. Wickramasinghe SN, Thein SL, Srichairatanakool S, Porter JB. Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I. Br J Haematol. 1999;107(3):522–5. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103–5. Bader-Meunier B, Leverger G, Tchernia G, et al. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French children. J Pediatr Hematol Oncol. 2005;27:416–9. Wickramasinghe SN, Pippard MJ. Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells. J Clin Pathol. 1986;39:881–90. Jean R, Dossa D, Navarro M, et al. Congenital aplastic anemia, type I. Arch Fr Pediatr. 1975;32:337–48. Heimpel H, Forteza-Vila J, Queisser W, Spiertz E. Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia. Blood. 1971;37:299–310. Alloisio N, Jaccoud P, Dorleac E, et al. Alterations of globin chain synthesis and of red cell membrane proteins in congenital dyserythropoietic anemia I and II. Pediatr Res. 1982;16:1016–21. Tamary H, Shalmon L, Shalev H, et al. Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1–15.3. Am J Hum Genet. 1998;62:1062–9. Tamary H, Dgany O, Proust A, et al. Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol. 2005;130:628–34. Iolascon A, Delaunay J. Close to unraveling the secrets of congenital dyserythropoietic anemia type I and II. Haematologica. 2009;94:599–602. Noy-Lotan S, Dgany O, Lahmi R, et al. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1) is cell cycle-regulated. Haematologica. 2009;94:629–37. Perrotta S, del Giudice EM, Carbone R, et al. Gilbert’s syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II). J Pediatr. 2000;136:556–9. Gasparini P, Miraglia del Giudice E, Delaunay J, et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genome wide search. Am J Hum Genet. 1997;61:1112–6. Lanzara C, Ficarella R, Totaro A, et al. Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes. Blood Cells Mol Dis. 2003;30:22–9. Schwarz K, Iolascon A, Verissimo F, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009;41:936–40. Jones B, Jones EL, Bonney SA, et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet. 2003;34:29–31. Boyadjiev SA, Fromme JC, Ben J, et al. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat Genet. 2006;38:1192–7. Iolascon A, Russo R, Esposito MR, et al. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype–phenotype relationship. Haematologica. 2010;95:708–15. Sandstorm H, Wahlin A. Congenital dyserythropoietic anemia type III. Haematologica. 2000;85:737–57. Wolff JA, Von Hofe FH. Familial erythroid multinuclearity. Blood. 1951;6:1274–83. Bergstorm I, Jacobsson L. Hereditary benign erythroreticulosis. Blood. 1962;19:296–303. Lind L, Sandstorm H, Wahlin A, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21–q25. Hum Mol Genet. 1995;4:109–12. Sandstorm H, Wahlin A, Eriksson M, et al. Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anemia, type III. Eur J Haematol. 1994;52:42–6. Byrnes RK, Dhru R, Brady AM, et al. Congenital dyserythropoietic anemia in treated Hodgkin’s disease. Hum Pathol. 1980;11:485–6. McCluggage WG, Hull D, Mayne E, et al. Malignant lymphoma in congenital dyserythropoietic anaemia type III. J Clin Pathol. 1996;49:599–602. Wickramasinghe SN, Parry TE, Williams C, et al. A new case of congenital dyserythropoietic anaemia, type III: studied of the cell cycle distribution and ultrastructure of erythroblasts and of nucleic acid synthesis in marrow cells. J Clin Pathol. 1982;35:1103–9. Wickramasinghe SN, Wahlin A, Anstee D, et al. Observations on two members of the Swedish family with congenital dyserythropoietic anaemia, type III. Eur J Haematol. 1993;50:213–21. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266–70. Taga T, Itoh T, Asami K, et al. Congenital dyserythropoietic anemia in Japanese children. Jpn J Pediatr Hematol. 2008;22:233–8 (in Japanese).